These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 79515)

  • 1. Repair of potentially lethal damage after single injection or continuous infusion of bleomycin.
    Suzuki Y; Urano M; Ando K; Todoroki T; Koike S
    Gan; 1978 Apr; 69(2):195-9. PubMed ID: 79515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of bleomycin in radiotherapy of a mouse mammary carcinoma.
    Urano M; Ando K; Koike S; Ohara K; Nesumi N
    Gan; 1976 Apr; 67(2):157-63. PubMed ID: 61143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of continuous bleomycin infusion on the growth and cell kinetics of heterotransplanted squamous cell carcinoma of the head and neck.
    Wahlberg P; Wennerberg J; Alm P; Biörklund A; Tropé C
    Anticancer Res; 1987; 7(1):55-8. PubMed ID: 2436565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose fractionation does not prevent repair of potentially lethal damage induced by bleomycin (NSC-125066) in vivo.
    Twentyman PR
    Cancer Treat Rep; 1976 Mar; 60(3):259-60. PubMed ID: 57001
    [No Abstract]   [Full Text] [Related]  

  • 5. Repair of potentially lethal radiation damage in acute and chronically hypoxic tumor cells in vivo.
    Urano M; Nesumi N; Ando K; Koike S; Ohnuma N
    Radiology; 1976 Feb; 118(2):447-51. PubMed ID: 1250982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of corynebacterium liquefaciens on a C3Hf mouse squamous cell carcinoma.
    Ando K; Urano M; Nesumi N; Koike S
    Cancer Res; 1977 Sep; 37(9):3115-9. PubMed ID: 884666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of continuous bleomycin treatment and of oil-suspended bleomycin on experimental tumor growth (author's transl)].
    Urano M; Koike S; Ando K; Nesumi N; Sukuki Y
    Jpn J Antibiot; 1976 Aug; 29(8):721-4. PubMed ID: 60500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of a continuous infusion with a daily bolus injection of bleomycin in a heterotransplanted human testicular cancer].
    Osieka R
    Arzneimittelforschung; 1984; 34(4):460-4. PubMed ID: 6204651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved therapeutic index of bleomycin when administered by continuous infusion in mice.
    Sikic BI; Collins JM; Mimnaugh EG; Gram TE
    Cancer Treat Rep; 1978 Dec; 62(12):2011-7. PubMed ID: 87269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the mode of administration of mitomycin on tumor and marrow response and on the therapeutic ratio.
    Rockwell S; Nierenburg M; Irvin CG
    Cancer Treat Rep; 1987 Oct; 71(10):927-34. PubMed ID: 3652056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment.
    Holden SA; Teicher BA; Boeheim K; Weichselbaum RR; Ervin TJ
    Br J Cancer; 1987 Mar; 55(3):245-8. PubMed ID: 2436643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion versus intermittent bolus injection of bleomycin in a human embryonal testicular cancer xenograft.
    Osieka R; Glatte P; Schmidt CG
    Cancer Treat Rep; 1984 May; 68(5):799-801. PubMed ID: 6202408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin: mammalian cell lethality and cellular basis of optimal schedule.
    Takabe Y; Miyamoto T; Watanabe M; Terasima T
    J Natl Cancer Inst; 1977 Oct; 59(4):1251-5. PubMed ID: 71355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
    Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1999; 17(4):259-64. PubMed ID: 10510897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancies between patterns of potentially lethal damage repair in the RIF-1 tumor system in vitro and in vivo.
    Rasey JS; Nelson NJ
    Radiat Res; 1983 Jan; 93(1):157-74. PubMed ID: 6337381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of mammalian cells to bleomycin-induced potentially lethal and sublethal damage.
    Barranco SC; Humphrey RM
    Prog Biochem Pharmacol; 1976; 11():78-92. PubMed ID: 63973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repair of radiation damage in Lewis lung carcinoma cells following in situ treatment with fast neutrons and gamma-rays.
    Shipley WU; Stanley JA; Courtenay VD; Field SB
    Cancer Res; 1975 Apr; 35(4):932-8. PubMed ID: 1120301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two types of lethal damage induced by pepleomycin in cultured Chinese hamster V79 cells.
    Saito T; Kamata R; Okada S
    Gan; 1984 Feb; 75(2):143-50. PubMed ID: 6203804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of the pulmonary toxicity of continuously infused bleomycin.
    Cooper KR; Hong WK
    Cancer Treat Rep; 1981; 65(5-6):419-25. PubMed ID: 6165471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on recovery from chemically induced damage in mammalian cells.
    Barranco SC; Novak JK; Humphrey RM
    Cancer Res; 1975 May; 35(5):1194-204. PubMed ID: 47265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.